表紙
市場調查報告書

全球子宮癌診斷檢驗市場分析

Global Market Study on Uterine Cancer Diagnostic Testing: Endometrium Carcinoma Segment to Lead in Terms of Value Through 2026

出版商 Persistence Market Research 商品編碼 718329
出版日期 內容資訊 英文 241 Pages
商品交期: 2-3個工作天內
價格
全球子宮癌診斷檢驗市場分析 Global Market Study on Uterine Cancer Diagnostic Testing: Endometrium Carcinoma Segment to Lead in Terms of Value Through 2026
出版日期: 2018年09月05日內容資訊: 英文 241 Pages
簡介

全球子宮癌診斷檢驗市場,預計從2018年到2026年以7.8%的年複合成長率發展。

本報告提供全球子宮癌診斷檢驗市場調查,各疾病類型、檢驗類型、終端用戶、地區、國家的市場規模的變化與預測(過去5年、今後8年份),市場趨勢,市場成長要素及阻礙因素分析,市場機會,競爭情形,主要企業的簡介等全面性資訊。

目錄

第1章 摘要整理

第2章 市場介紹

  • 市場定義
  • 市場分類

第3章 市場概要

  • 宏觀經濟要素
  • 成長要素及阻礙因素
  • 市場機會
  • 主要趨勢
  • 償付方案

第4章 重要添加資料

  • 平均價格分析:各地區
  • 前幾名市場評估
  • 流行病學

第5章 北美的子宮癌診斷檢驗市場

  • 簡介
  • 市場規模的變化與預測:各國
    • 美國
    • 加拿大
  • 市場規模的變化與預測:各疾病類型
    • 子宮肉瘤
    • 子宮內膜癌
  • 市場規模的變化與預測:各檢驗類型
    • 超音波掃描
    • 切片檢查
    • 血液檢驗
  • 市場規模的變化與預測:各終端用戶
    • 醫院
    • 門診外科中心
    • 癌症研究中心
    • 專門診所
    • 診斷研究所
    • 其他
  • 成長要素及阻礙因素:影響分析
  • 市場魅力分析:各市場區隔

第6章 南美的子宮癌診斷檢驗市場

  • 簡介
  • 市場規模的變化與預測:各國
    • 巴西
    • 墨西哥
  • 市場規模的變化與預測:各疾病類型
  • 市場規模的變化與預測:各檢驗類型
  • 市場規模的變化與預測:各終端用戶
  • 成長要素及阻礙因素:影響分析
  • 市場魅力分析:各市場區隔

第7章 歐洲的子宮癌診斷檢驗市場

  • 簡介
  • 市場規模的變化與預測:各國
    • 德國
    • 英國
    • 法國
    • 義大利
    • 西班牙
    • 波蘭
    • 俄羅斯
    • 其他
  • 市場規模的變化與預測:各疾病類型
  • 市場規模的變化與預測:各檢驗類型
  • 市場規模的變化與預測:各終端用戶
  • 成長要素及阻礙因素:影響分析
  • 市場魅力分析:各市場區隔

第8章 中國以外亞太地區的子宮癌診斷檢驗市場

  • 簡介
  • 市場規模的變化與預測:各國
    • 中國
    • 印度
    • 日本
    • 澳洲、紐西蘭
    • 其他
  • 市場規模的變化與預測:各疾病類型
  • 市場規模的變化與預測:各檢驗類型
  • 市場規模的變化與預測:各終端用戶
  • 成長要素及阻礙因素:影響分析
  • 市場魅力分析:各市場區隔

第9章 中國的子宮癌診斷檢驗市場

  • 簡介
  • 市場規模的變化與預測
  • 市場規模的變化與預測:各疾病類型
  • 市場規模的變化與預測:各檢驗類型
  • 市場規模的變化與預測:各終端用戶
  • 成長要素及阻礙因素:影響分析
  • 市場魅力分析:各市場區隔

第10章 中東、非洲的子宮癌診斷檢驗市場

  • 簡介
  • 市場規模的變化與預測:各國
    • 南非
    • 沙烏地阿拉伯
    • 其他
  • 市場規模的變化與預測:各疾病類型
  • 市場規模的變化與預測:各檢驗類型
  • 市場規模的變化與預測:各終端用戶
  • 成長要素及阻礙因素:影響分析
  • 市場魅力分析:各市場區隔

第11章 預測要素:相關性和影響力

第12章 競爭情形

  • 競爭儀表板
  • 企業簡介(詳細內容 - 概要,財務,策略,最新趨勢)
  • 主要企業
    • Abbott
    • Roche Holdings AG
    • Siemens AG
    • Danaher
    • BioMerieux SA

第13章 全球子宮癌診斷檢驗市場:各地區

第14章 全球子宮癌診斷檢驗市場:各疾病類型

第15章 全球子宮癌診斷檢驗市場:各診斷檢查

第16章 全球子宮癌診斷檢驗市場:各終端用戶

第17章 市場分析與預測

  • 市場規模與成長率

第18章 縮寫

第19章 調查方法

目錄

Persistence Market Research offers an eight year forecast on the global Uterine Cancer Diagnostic Testing market. The primary objective of the report is to offer updates and information related to market opportunities in the Uterine Cancer Diagnostic Testing market.

In terms of revenue, the global Uterine Cancer Diagnostic Testing market is expected to register a CAGR of 7.8% during the forecast period, 2018-2026. The primary objective of the report is to offer insights on the market dynamics that can influence the growth of the global Uterine Cancer Diagnostic Testing market over the forecast period. Insights on key trends, drivers, restraints, value forecasts and opportunities for companies operating in the global Uterine Cancer Diagnostic Testing market are presented in the report.

The global market for Uterine Cancer Diagnostic Testing is expected to witness high growth rate in terms of value in high economic countries due to increase in incidence of uterine cancer cases and efficient healthcare infrastructure. Increase in healthcare expenditure and rising women geriatric population has also driven the market for Uterine Cancer Diagnostic Testing. Low and Middle economy countries like India and South Africa have a lower incidence rate for uterine cancer. The diagnosis rate is poor in these countries and thus, these countries witness low growth rate in terms of value for Uterine Cancer Diagnostic Testing market.

The report includes Uterine Cancer Diagnostic Test types like ultrasound scanning, biopsy procedures and blood tests. Ultrasound scanning has further been segmented into abdominal ultrasound scanning and transvaginal ultrasound scanning. Biopsy procedures include endometrial biopsy, hysteroscopy and dilation & curettage. Blood tests include a complete blood count test, also known as CBC and CA125 marker blood test.

However, the report does not include revenue generated by the imaging procedures like CT scans, MRI scans, X-Rays, PET scans, endoscopy procedures and other screening & treatment methods. Currency fluctuations and inflation are not considered while calculating the revenue of the Uterine Cancer Diagnostic Testing market.

Revenue from the Uterine Cancer Diagnostic Testing market in North America is expected to expand at a relatively higher CAGR due to growing awareness of women health and gynaecologic cancer. High incidence rates also contribute to the market for Uterine Cancer Diagnostic Testing in the region. To understand and assess the opportunities in this market, the report offers the market forecast on the basis of segment type classified into the cancer type, diagnostic test type, end users and regions. The report provides analysis of the global Uterine Cancer Diagnostic Testing market in terms of market value (US$ Mn).

The global Uterine Cancer Diagnostic Testing market is segmented on the basis of cancer type into:

Endometrial Carcinoma

Uterine Sarcoma

The report begins with the market definition of Uterine Cancer Diagnostic Testing, followed by definitions of different cancer and diagnostic test types. The market dynamics section includes PMR's analysis on key trends, drivers, restraints, opportunities, macro-economic factors and reimbursement scenario influencing the growth of the global Uterine Cancer Diagnostic Testing market.

The report analyses the Uterine Cancer Diagnostic Testing market on the basis of diagnostic test type and end users and presents forecast in terms of value for the next 8 years. On the basis of diagnostic test type, the global Uterine Cancer Diagnostic Testing market is segmented into:

Ultrasound Scanning

Abdominal Ultrasound Scanning

Transvaginal Ultrasound Scanning

Biopsy Procedures

Endometrial Biopsy

Hysteroscopy

Dilation & Curettage

Blood Tests

Complete Blood Count

CA125 Marker Blood Test

On the basis of the end users, the global Uterine Cancer Diagnostic Testing market is segmented into:

Hospitals

Ambulatory Surgical Centers

Cancer Research Institutes

Specialized Clinics

Diagnostic Laboratories

Others

Next, the report analyses the market on the basis of regions and presents forecast in terms of value for the next 8 years. On the basis of region, the global Uterine Cancer Diagnostic Testing market is segmented into:

North America

U.S.

Canada

Latin America

Brazil

Mexico

Rest of Latin America

Europe

Germany

France

U.K.

Italy

Poland

Spain

Russia

Rest of Europe

Asia Pacific excluding China

India

China

Australia & New Zealand

ASEAN

Rest of Asia- Pacific excluding China

China

Middle East & Africa (MEA)

Saudi Arabia

South Africa

Rest of Middle East and Africa

In addition, we have considered Year-on-Year (Y-o-Y) growth to understand the predictability of the market and identify growth opportunities for companies operating in the global Uterine Cancer Diagnostic Testing market.

Another key feature of this report is the analysis of key segments in terms of absolute dollar opportunity. This is usually overlooked while forecasting the market. However, absolute dollar opportunity is critical for assessing the level of opportunity that a provider can look to achieve, as well as to identify potential resources from a sales and delivery perspective for services offered by the Uterine Cancer Diagnostic Testing market. To understand the key segments in terms of their growth and performance in the global Uterine Cancer Diagnostic Testing market, Persistence Market Research has developed a market attractiveness index. The resulting index will help identify the existing market opportunities in Uterine Cancer Diagnostic Testing market.

In the final section of the report, a 'competitive landscape' has been included to provide a dashboard view of the key companies operating in the global Uterine Cancer Diagnostic Testing market. This section is primarily designed to provide clients with an objective and detailed comparative assessment of the key providers specific to a market segment in the Uterine Cancer Diagnostic Testing market. However, this section also includes market strategies and SWOT analysis of the key players operating in the global Uterine Cancer Diagnostic Testing market.

Detailed profiles of Uterine Cancer Diagnostic Testing drug manufacturers are also included in the scope of the report to evaluate their long- and short-term strategies. Examples of some of the key players operating in the Uterine Cancer Diagnostic Testing market are Abbott, Roche Holdings AG, Siemens, Danaher and Biomerieux SA.

Table of Contents

1. Executive Summary

  • 1.1. Market Overview
  • 1.2. Market Analysis
  • 1.3. PMR Analysis and Recommendations
  • 1.4. Wheel of Fortune

2. Market Introduction

  • 2.1. Market Definition
  • 2.2. Market Taxonomy

3. Uterine Cancer Diagnostic Testing Market View Point

  • 3.1. Macro-Economic Factors
  • 3.2. Market Drivers and Restraints
  • 3.3. Opportunity Analysis
  • 3.4. Global Key trends
  • 3.5. Reimbursement Scenario

4. Global Uterine Cancer Diagnostic Testing Market - Key Inclusions

  • 4.1. Regional Average Pricing Analysis
  • 4.2. Parent Market Assessment
  • 4.3. Epidemiology

5. North America Uterine Cancer Diagnostic Testing Market Analysis 2013-2017 and Forecast 2018-2026

  • 5.1. Introduction
  • 5.2. Historical Market Size (US$ Mn) By Country, 2013-2017
    • 5.2.1. U.S.
    • 5.2.2. Canada
  • 5.3. Market Size (US$ Mn) Forecast By Country, 2018-2026
    • 5.3.1. U.S.
    • 5.3.2. Canada
  • 5.4. Historical Market Size (US$ Mn) By Cancer Type, 2013-2017
    • 5.4.1. Uterine Sarcoma
    • 5.4.2. Endometrial Carcinomas
  • 5.5. Market Size (US$ Mn) Forecast By Cancer Type, 2018-2026
    • 5.5.1. Uterine Sarcoma
    • 5.5.2. Endometrial Carcinomas
  • 5.6. Historical Market Size (US$ Mn) By Test Type, 2013-2017
    • 5.6.1. Ultrasound Scanning
      • 5.6.1.1. Abdominal Ultrasound
      • 5.6.1.2. Transvaginal Ultrasound
    • 5.6.2. Biopsy
      • 5.6.2.1. Endometrial Biopsy
      • 5.6.2.2. Hysteroscopy
      • 5.6.2.3. Dilation and curettage
    • 5.6.3. Blood tests
      • 5.6.3.1. Complete blood Count
      • 5.6.3.2. CA-125 blood test
  • 5.7. Market Size (US$ Mn) Forecast By Test Type, 2018-2026
    • 5.7.1. Ultrasound Scanning
        • 5.7.1.1.1. Abdominal Ultrasound
        • 5.7.1.1.2. Transvaginal Ultrasound
    • 5.7.2. Biopsy
      • 5.7.2.1. Endometrial Biopsy
      • 5.7.2.2. Hysteroscopy
      • 5.7.2.3. Dilation and curettage
    • 5.7.3. Blood tests
      • 5.7.3.1. Complete blood Count
      • 5.7.3.2. CA-125 blood test
  • 5.8. Historical Market Size Analysis 2013-2017, By End User
    • 5.8.1. Hospitals
    • 5.8.2. Ambulatory Surgical Centers
    • 5.8.3. Cancer Research Centers
    • 5.8.4. Specialized Clinics
    • 5.8.5. Diagnostic Laboratories
    • 5.8.6. Others
  • 5.9. Market Size Analysis 2018-2026, By End User
    • 5.9.1. Hospitals
    • 5.9.2. Ambulatory Surgical Centers
    • 5.9.3. Cancer Research Centers
    • 5.9.4. Specialized Clinics
    • 5.9.5. Diagnostic Laboratories
    • 5.9.6. Others
  • 5.10. Drivers and Restraints: Impact Analysis
  • 5.11. Market Attractiveness Analysis
    • 5.11.1. By Cancer Type
    • 5.11.2. By Test Type
    • 5.11.3. By End user
    • 5.11.4. By Country

6. Latin America Uterine Cancer Diagnostic Testing Market Analysis 2013-2017 and Forecast 2018-2026

  • 6.1. Introduction
  • 6.2. Historical Market Size (US$ Mn) By Country, 2013-2017
    • 6.2.1. Brazil
    • 6.2.2. Mexico
    • 6.2.3. Rest of Latin America
  • 6.3. Market Size (US$ Mn) Forecast By Country, 2018-2026
    • 6.3.1. Brazil
    • 6.3.2. Mexico
    • 6.3.3. Rest of Latin America
  • 6.4. Historical Market Size (US$ Mn) By Cancer Type, 2013-2017
    • 6.4.1. Uterine Sarcoma
    • 6.4.2. Endometrial Carcinomas
  • 6.5. Market Size (US$ Mn) Forecast By Cancer Type, 2018-2026
    • 6.5.1. Uterine Sarcoma
    • 6.5.2. Endometrial Carcinomas
  • 6.6. Historical Market Size (US$ Mn) By Test Type, 2013-2017
    • 6.6.1. Ultrasound Scanning
        • 6.6.1.1.1. Abdominal Ultrasound
        • 6.6.1.1.2. Transvaginal Ultrasound
    • 6.6.2. Biopsy
        • 6.6.2.1.1. Endometrial Biopsy
        • 6.6.2.1.2. Hysteroscopy
        • 6.6.2.1.3. Dilation and curettage
    • 6.6.3. Blood tests
        • 6.6.3.1.1. Complete blood Count
        • 6.6.3.1.2. CA-125 blood test
  • 6.7. Market Size (US$ Mn) Forecast By Test Type, 2018-2026
    • 6.7.1. Ultrasound Scanning
        • 6.7.1.1.1. Abdominal Ultrasound
        • 6.7.1.1.2. Transvaginal Ultrasound
    • 6.7.2. Biopsy
        • 6.7.2.1.1. Endometrial Biopsy
        • 6.7.2.1.2. Hysteroscopy
        • 6.7.2.1.3. Dilation and curettage
    • 6.7.3. Blood tests
        • 6.7.3.1.1. Complete blood Count
        • 6.7.3.1.2. CA-125 blood test
  • 6.8. Historical Market Size Analysis 2013-2017, By End User
    • 6.8.1. Hospitals
    • 6.8.2. Ambulatory Surgical Centers
    • 6.8.3. Cancer Research Centers
    • 6.8.4. Specialized Clinics
    • 6.8.5. Diagnostic Laboratories
    • 6.8.6. Others
  • 6.9. Market Size Analysis 2018-2026, By End User
    • 6.9.1. Hospitals
    • 6.9.2. Ambulatory Surgical Centers
    • 6.9.3. Cancer Research Centers
    • 6.9.4. Specialized Clinics
    • 6.9.5. Diagnostic Laboratories
    • 6.9.6. Others
  • 6.10. Drivers and Restraints: Impact Analysis
  • 6.11. Market Attractiveness Analysis
    • 6.11.1. By Cancer Type
    • 6.11.2. By Test Type
    • 6.11.3. By End user
    • 6.11.4. By Country

7. Europe Uterine Cancer Diagnostic Testing Market Analysis 2013-2017 and Forecast 2018-2026

  • 7.1. Introduction
  • 7.2. Historical Market Size (US$ Mn) By Country, 2013-2017
    • 7.2.1. Germany
    • 7.2.2. U.K.
    • 7.2.3. France
    • 7.2.4. Italy
    • 7.2.5. Spain
    • 7.2.6. Poland
    • 7.2.7. Russia
    • 7.2.8. Rest of Europe
  • 7.3. Market Size (US$ Mn) Forecast By Country, 2018-2026
    • 7.3.1. Germany
    • 7.3.2. U.K.
    • 7.3.3. France
    • 7.3.4. Italy
    • 7.3.5. Spain
    • 7.3.6. Poland
    • 7.3.7. Russia
    • 7.3.8. Rest of Europe
  • 7.4. Historical Market Size (US$ Mn) By Cancer Type, 2013-2017
    • 7.4.1. Uterine Sarcoma
    • 7.4.2. Endometrial Carcinomas
  • 7.5. Market Size (US$ Mn) Forecast By Cancer Type, 2018-2026
    • 7.5.1. Uterine Sarcoma
    • 7.5.2. Endometrial Carcinomas
  • 7.6. Historical Market Size (US$ Mn) By Test Type, 2013-2017
    • 7.6.1. Ultrasound Scanning
        • 7.6.1.1.1. Abdominal Ultrasound
        • 7.6.1.1.2. Transvaginal Ultrasound
    • 7.6.2. Biopsy
        • 7.6.2.1.1. Endometrial Biopsy
        • 7.6.2.1.2. Hysteroscopy
        • 7.6.2.1.3. Dilation and curettage
    • 7.6.3. Blood tests
        • 7.6.3.1.1. Complete blood Count
        • 7.6.3.1.2. CA-125 blood test
  • 7.7. Market Size (US$ Mn) Forecast By Test Type, 2018-2026
    • 7.7.1. Ultrasound Scanning
        • 7.7.1.1.1. Abdominal Ultrasound
        • 7.7.1.1.2. Transvaginal Ultrasound
    • 7.7.2. Biopsy
        • 7.7.2.1.1. Endometrial Biopsy
        • 7.7.2.1.2. Hysteroscopy
        • 7.7.2.1.3. Dilation and curettage
    • 7.7.3. Blood tests
        • 7.7.3.1.1. Complete blood Count
        • 7.7.3.1.2. CA-125 blood test
  • 7.8. Historical Market Size Analysis 2013-2017, By End User
    • 7.8.1. Hospitals
    • 7.8.2. Ambulatory Surgical Centers
    • 7.8.3. Cancer Research Centers
    • 7.8.4. Specialized Clinics
    • 7.8.5. Diagnostic Laboratories
    • 7.8.6. Others
  • 7.9. Market Size Analysis 2018-2026, By End User
    • 7.9.1. Hospitals
    • 7.9.2. Ambulatory Surgical Centers
    • 7.9.3. Cancer Research Centers
    • 7.9.4. Specialized Clinics
    • 7.9.5. Diagnostic Laboratories
    • 7.9.6. Others
  • 7.10. Drivers and Restraints: Impact Analysis
  • 7.11. Market Attractiveness Analysis
    • 7.11.1. By Cancer Type
    • 7.11.2. By Test Type
    • 7.11.3. By End user
    • 7.11.4. By Country

8. Asia Pacific Excluding China Uterine Cancer Diagnostic Testing Market Analysis 2013-2017 and Forecast 2018-2026

  • 8.1. Introduction
  • 8.2. Historical Market Size (US$ Mn) By Country, 2013-2017
    • 8.2.1. China
    • 8.2.2. India
    • 8.2.3. Japan
    • 8.2.4. Australia and New Zealand
    • 8.2.5. Rest of APAC
  • 8.3. Market Size (US$ Mn) Forecast By Country, 2018-2026
    • 8.3.1. China
    • 8.3.2. India
    • 8.3.3. Japan
    • 8.3.4. Australia and New Zealand
    • 8.3.5. Rest of APAC
  • 8.4. Historical Market Size (US$ Mn) By Cancer Type, 2013-2017
    • 8.4.1. Uterine Sarcoma
    • 8.4.2. Endometrial Carcinomas
  • 8.5. Market Size (US$ Mn) Forecast By Cancer Type, 2018-2026
    • 8.5.1. Uterine Sarcoma
    • 8.5.2. Endometrial Carcinomas
  • 8.6. Historical Market Size (US$ Mn) By Test Type, 2013-2017
    • 8.6.1. Ultrasound Scanning
        • 8.6.1.1.1. Abdominal Ultrasound
        • 8.6.1.1.2. Transvaginal Ultrasound
    • 8.6.2. Biopsy
        • 8.6.2.1.1. Endometrial Biopsy
        • 8.6.2.1.2. Hysteroscopy
        • 8.6.2.1.3. Dilation and curettage
    • 8.6.3. Blood tests
        • 8.6.3.1.1. Complete blood Count
        • 8.6.3.1.2. CA-125 blood test
  • 8.7. Market Size (US$ Mn) Forecast By Test Type, 2018-2026
    • 8.7.1. Ultrasound Scanning
        • 8.7.1.1.1. Abdominal Ultrasound
        • 8.7.1.1.2. Transvaginal Ultrasound
    • 8.7.2. Biopsy
        • 8.7.2.1.1. Endometrial Biopsy
        • 8.7.2.1.2. Hysteroscopy
        • 8.7.2.1.3. Dilation and curettage
    • 8.7.3. Blood tests
        • 8.7.3.1.1. Complete blood Count
        • 8.7.3.1.2. CA-125 blood test
  • 8.8. Historical Market Size Analysis 2013-2017, By End User
    • 8.8.1. Hospitals
    • 8.8.2. Ambulatory Surgical Centers
    • 8.8.3. Cancer Research Centers
    • 8.8.4. Specialized Clinics
    • 8.8.5. Diagnostic Laboratories
    • 8.8.6. Others
  • 8.9. Market Size Analysis 2018-2026, By End User
    • 8.9.1. Hospitals
    • 8.9.2. Ambulatory Surgical Centers
    • 8.9.3. Cancer Research Centers
    • 8.9.4. Specialized Clinics
    • 8.9.5. Diagnostic Laboratories
    • 8.9.6. Others
  • 8.10. Drivers and Restraints: Impact Analysis
  • 8.11. Market Attractiveness Analysis
    • 8.11.1. By Cancer Type
    • 8.11.2. By Test Type
    • 8.11.3. By End user
    • 8.11.4. By Country

9. China Uterine Cancer Diagnostic Testing Market Analysis 2013-2017 and Forecast 2018-2026

  • 9.1. Introduction
  • 9.2. Historical Market Size (US$ Mn) By Cancer Type, 2013-2017
    • 9.2.1. Uterine Sarcoma
    • 9.2.2. Endometrial Carcinomas
  • 9.3. Market Size (US$ Mn) Forecast By Cancer Type, 2018-2026
    • 9.3.1. Uterine Sarcoma
    • 9.3.2. Endometrial Carcinomas
  • 9.4. Historical Market Size (US$ Mn) By Test Type, 2013-2017
    • 9.4.1. Ultrasound Scanning
        • 9.4.1.1.1. Abdominal Ultrasound
        • 9.4.1.1.2. Transvaginal Ultrasound
    • 9.4.2. Biopsy
        • 9.4.2.1.1. Endometrial Biopsy
        • 9.4.2.1.2. Hysteroscopy
        • 9.4.2.1.3. Dilation and curettage
    • 9.4.3. Blood tests
        • 9.4.3.1.1. Complete blood Count
        • 9.4.3.1.2. CA-125 blood test
  • 9.5. Market Size (US$ Mn) Forecast By Test Type, 2018-2026
    • 9.5.1. Ultrasound Scanning
        • 9.5.1.1.1. Abdominal Ultrasound
        • 9.5.1.1.2. Transvaginal Ultrasound
    • 9.5.2. Biopsy
        • 9.5.2.1.1. Endometrial Biopsy
        • 9.5.2.1.2. Hysteroscopy
        • 9.5.2.1.3. Dilation and curettage
    • 9.5.3. Blood tests
        • 9.5.3.1.1. Complete blood Count
        • 9.5.3.1.2. CA-125 blood test
  • 9.6. Historical Market Size Analysis 2013-2017, By End User
    • 9.6.1. Hospitals
    • 9.6.2. Ambulatory Surgical Centers
    • 9.6.3. Cancer Research Centers
    • 9.6.4. Specialized Clinics
    • 9.6.5. Diagnostic Laboratories
    • 9.6.6. Others
  • 9.7. Market Size Analysis 2018-2026, By End User
    • 9.7.1. Hospitals
    • 9.7.2. Ambulatory Surgical Centers
    • 9.7.3. Cancer Research Centers
    • 9.7.4. Specialized Clinics
    • 9.7.5. Diagnostic Laboratories
    • 9.7.6. Others
  • 9.8. Drivers and Restraints: Impact Analysis
  • 9.9. Market Attractiveness Analysis
    • 9.9.1. By Cancer Type
    • 9.9.2. By Test Type
    • 9.9.3. By End user
    • 9.9.4. By Country

10. Middle East and Africa (MEA) Uterine Cancer Diagnostic Testing Market Analysis 2013-2017 and Forecast 2018-2026

  • 10.1. Introduction
  • 10.2. Historical Market Size (US$ Mn) By Country, 2013-2017
    • 10.2.1. South Africa
    • 10.2.2. Saudi Arabia
    • 10.2.3. Rest of MEA
  • 10.3. Market Size (US$ Mn) Forecast By Country, 2018-2026
    • 10.3.1. South Africa
    • 10.3.2. Saudi Arabia
    • 10.3.3. Rest of MEA
  • 10.4. Historical Market Size (US$ Mn) By Cancer Type, 2013-2017
    • 10.4.1. Uterine Sarcoma
    • 10.4.2. Endometrial Carcinomas
  • 10.5. Market Size (US$ Mn) Forecast By Cancer Type, 2018-2026
    • 10.5.1. Uterine Sarcoma
    • 10.5.2. Endometrial Carcinomas
  • 10.6. Historical Market Size (US$ Mn) By Test Type, 2013-2017
    • 10.6.1. Ultrasound Scanning
        • 10.6.1.1.1. Abdominal Ultrasound
        • 10.6.1.1.2. Transvaginal Ultrasound
    • 10.6.2. Biopsy
        • 10.6.2.1.1. Endometrial Biopsy
        • 10.6.2.1.2. Hysteroscopy
        • 10.6.2.1.3. Dilation and curettage
    • 10.6.3. Blood tests
        • 10.6.3.1.1. Complete blood Count
        • 10.6.3.1.2. CA-125 blood test
  • 10.7. Market Size (US$ Mn) Forecast By Test Type, 2018-2026
    • 10.7.1. Ultrasound Scanning
        • 10.7.1.1.1. Abdominal Ultrasound
        • 10.7.1.1.2. Transvaginal Ultrasound
    • 10.7.2. Biopsy
        • 10.7.2.1.1. Endometrial Biopsy
        • 10.7.2.1.2. Hysteroscopy
        • 10.7.2.1.3. Dilation and curettage
    • 10.7.3. Blood tests
        • 10.7.3.1.1. Complete blood Count
        • 10.7.3.1.2. CA-125 blood test
  • 10.8. Historical Market Size Analysis 2013-2017, By End User
    • 10.8.1. Hospitals
    • 10.8.2. Ambulatory Surgical Centers
    • 10.8.3. Cancer Research Centers
    • 10.8.4. Specialized Clinics
    • 10.8.5. Diagnostic Laboratories
    • 10.8.6. Others
  • 10.9. Market Size Analysis 2018-2026, By End User
    • 10.9.1. Hospitals
    • 10.9.2. Ambulatory Surgical Centers
    • 10.9.3. Cancer Research Centers
    • 10.9.4. Specialized Clinics
    • 10.9.5. Diagnostic Laboratories
    • 10.9.6. Others
  • 10.10. Drivers and Restraints: Impact Analysis
  • 10.11. Market Attractiveness Analysis
    • 10.11.1. By Cancer Type
    • 10.11.2. By Test Type
    • 10.11.3. By End user
    • 10.11.4. By Country

11. Forecast Factors: Relevance and Impact

12. Competition Landscape

  • 12.1. Competition Dashboard
  • 12.2. Company Profiles (Details - Overview, Financials, Strategy, Recent Developments)
  • 12.3. Key Players
    • 12.3.1. Abbott
    • 12.3.2. Roche Holdings AG
    • 12.3.3. Siemens AG
    • 12.3.4. Danaher
    • 12.3.5. BioMerieux SA

13. Global Uterine Cancer Diagnostic Testing Market Analysis 2013-2017 and Forecast 2018-2026, By Region

  • 13.1. Introduction
    • 13.1.1. Basis Point Share (BPS) Analysis by Region
    • 13.1.2. Y-o-Y Growth Projections by Region
  • 13.2. Historical Market Size Analysis 2013-2017, By Region
    • 13.2.1. North America
    • 13.2.2. Latin America
    • 13.2.3. Europe
    • 13.2.4. Asia Pacific Excluding China
    • 13.2.5. China
    • 13.2.6. Middle East and Africa (MEA)
  • 13.3. Market Size Analysis 2018-2026, By Region
    • 13.3.1. North America
    • 13.3.2. Latin America
    • 13.3.3. Europe
    • 13.3.4. Asia Pacific Excluding China
    • 13.3.5. China
    • 13.3.6. Middle East and Africa (MEA)
  • 13.4. Market Attractiveness Analysis by Region

14. Global Uterine Cancer Diagnostic Testing Market Analysis 2013-2017 and Forecast 2018-2026, By Cancer Type

  • 14.1. Introduction
    • 14.1.1. Basis Point Share (BPS) Analysis by Product Type
    • 14.1.2. Y-o-Y Growth Projections by Product Type
  • 14.2. Historical Market Size Analysis 2013-2017, By Cancer Type
    • 14.2.1. Uterine Sarcoma
    • 14.2.2. Endometrial Carcinomas
  • 14.3. Market Size Analysis 2018-2026, By Cancer Type
    • 14.3.1. Uterine Sarcoma
    • 14.3.2. Endometrial Carcinomas
  • 14.4. Market Attractiveness Analysis by Cancer Type

15. Global Uterine Cancer Diagnostic Testing Market Analysis 2013-2017 and Forecast 2018-2026, By Diagnostic Test Type

  • 15.1. Introduction
    • 15.1.1. Basis Point Share (BPS) Analysis by Test Type
    • 15.1.2. Y-o-Y Growth Projections by Test Type
  • 15.2. Historical Market Size Analysis 2013-2017, By Test Type
    • 15.2.1. Ultrasound Scanning
        • 15.2.1.1.1. Abdominal Ultrasound
        • 15.2.1.1.2. Transvaginal Ultrasound
    • 15.2.2. Biopsy
        • 15.2.2.1.1. Endometrial Biopsy
        • 15.2.2.1.2. Hysteroscopy
        • 15.2.2.1.3. Dilation and curettage
    • 15.2.3. Blood tests
        • 15.2.3.1.1. Complete blood Count
        • 15.2.3.1.2. CA-125 blood test
  • 15.3. Market Size Analysis 2018-2026, By Test Type
    • 15.3.1. Ultrasound Scanning
        • 15.3.1.1.1. Abdominal Ultrasound
        • 15.3.1.1.2. Transvaginal Ultrasound
    • 15.3.2. Biopsy
        • 15.3.2.1.1. Endometrial Biopsy
        • 15.3.2.1.2. Hysteroscopy
        • 15.3.2.1.3. Dilation and curettage
    • 15.3.3. Blood tests
        • 15.3.3.1.1. Complete blood Count
        • 15.3.3.1.2. CA-125 blood test
  • 15.4. Market Attractiveness Analysis by Test Type

16. Global Uterine Cancer Diagnostic Testing Market Analysis 2013-2017 and Forecast 2018-2026, By End User

  • 16.1. Introduction
    • 16.1.1. Basis Point Share (BPS) Analysis by End User
    • 16.1.2. Y-o-Y Growth Projections by End User
  • 16.2. Historical Market Size Analysis 2013-2017, By End User
    • 16.2.1. Hospitals
    • 16.2.2. Ambulatory Surgical Centers
    • 16.2.3. Cancer Research Centers
    • 16.2.4. Specialized Clinics
    • 16.2.5. Diagnostic Laboratories
    • 16.2.6. Others
  • 16.3. Market Size Analysis 2018-2026, By End User
    • 16.3.1. Hospitals
    • 16.3.2. Ambulatory Surgical Centers
    • 16.3.3. Cancer Research Centers
    • 16.3.4. Specialized Clinics
    • 16.3.5. Diagnostic Laboratories
    • 16.3.6. Others
  • 16.4. Market Attractiveness Analysis by End User

17. Global Uterine Cancer Diagnostic Testing Market Analysis 2013-2017 and Forecast 2017-2027

  • 17.1. Market Size and Y-o-Y Growth
  • 17.2. Absolute $ Opportunity

18. Assumptions and Acronyms Used

A glossary of assumption and acronyms used in the report

19. Research Methodology

List of Tables

  • Table 1: North America Uterine Cancer Diagnostic Testing Market Size Analysis (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By Country
  • Table 2: North America Uterine Cancer Diagnostic Testing Market Size Analysis (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By Cancer Type
  • Table 3: North America Uterine Cancer Diagnostic Testing Fraction Market Size Analysis (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By Diagnostic Test Type
  • Table 4: North America Uterine Cancer Diagnostic Testing Fraction Market Size Analysis (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By End-Users
  • Table 5: Latin America Uterine Cancer Diagnostic Testing Market Size Analysis (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By Country
  • Table 6: Latin America Uterine Cancer Diagnostic Testing Market Size Analysis (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By Cancer Type
  • Table 7: Latin America Uterine Cancer Diagnostic Testing Fraction Market Size Analysis (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By Diagnostic Test Type
  • Table 8: Latin America Uterine Cancer Diagnostic Testing Fraction Market Size Analysis (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By End-Users
  • Table 9: Europe Uterine Cancer Diagnostic Testing Market Size Analysis (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By Country
  • Table 10: Europe Uterine Cancer Diagnostic Testing Market Size Analysis (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By Cancer Type
  • Table 11: Europe Uterine Cancer Diagnostic Testing Fraction Market Size Analysis (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By Diagnostic Test Type
  • Table 12: Europe Uterine Cancer Diagnostic Testing Fraction Market Size Analysis (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By End-Users
  • Table 13: Asia-Pacific excluding China Uterine Cancer Diagnostic Testing Market Size Analysis (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By Country
  • Table 14: Asia-Pacific excluding China Uterine Cancer Diagnostic Testing Market Size Analysis (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By Cancer Type
  • Table 15: Asia-Pacific excluding China Uterine Cancer Diagnostic Testing Fraction Market Size Analysis (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By Diagnostic Test Type
  • Table 16: Asia-Pacific excluding China Uterine Cancer Diagnostic Testing Fraction Market Size Analysis (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By End-Users
  • Table 17: China Uterine Cancer Diagnostic Testing Market Size Analysis (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By Country
  • Table 18: China Uterine Cancer Diagnostic Testing Market Size Analysis (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By Cancer Type
  • Table 19: China Uterine Cancer Diagnostic Testing Fraction Market Size Analysis (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By Diagnostic Test Type
  • Table 20: China Uterine Cancer Diagnostic Testing Fraction Market Size Analysis (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By End-Users
  • Table 21: Middle East and Africa Uterine Cancer Diagnostic Testing Market Size Analysis (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By Country
  • Table 22: Middle East and Africa Uterine Cancer Diagnostic Testing Market Size Analysis (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By Cancer Type
  • Table 23: Middle East and Africa Uterine Cancer Diagnostic Testing Fraction Market Size Analysis (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By Diagnostic Test Type
  • Table 24: Middle East and Africa Uterine Cancer Diagnostic Testing Fraction Market Size Analysis (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By End-Users
  • Table 25: Global Uterine Cancer Diagnostic Testing Market size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By Region
  • Table 26: Global Uterine Cancer Diagnostic Testing Market size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By Cancer Type
  • Table 27: Global Uterine Cancer Diagnostic Testing Market Size Analysis (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By Diagnostic Test Type
  • Table 28: Global Uterine Cancer Diagnostic Testing Market size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By End User

List of Figures

  • Figure 1: Global Uterine Cancer Diagnostic Testing Market Share by Cancer Type (2017)
  • Figure 2: Global Uterine Cancer Diagnostic Testing Market Share by Diagnostic Test Type (2017)
  • Figure 3: Global Uterine Cancer Diagnostic Testing Market Share by End User (2017)
  • Figure 4: Global Uterine Cancer Diagnostic Testing Market Share by Region (2017)
  • Figure 5: Percentage share of uterine cancer type
  • Figure 6: Percentage share of diagnostic test type
  • Figure 7: Regional Average Pricing Analysis (US$) of Abdominal Ultrasound Scanning (2017)
  • Figure 8: Regional Average Pricing Analysis (US$) of Transvaginal Ultrasound Scanning (2017)
  • Figure 9: Regional Average Pricing Analysis (US$) of Endometrial Biopsy (2017)
  • Figure 10: Regional Average Pricing Analysis (US$) of Hysteroscopy (2017)
  • Figure 11: Regional Average Pricing Analysis (US$) of Dilation & Curettage (2017)
  • Figure 12: Regional Average Pricing Analysis (US$) of Complete Blood Count (2017)
  • Figure 13: Regional Average Pricing Analysis (US$) of CA125 Tumor marker Blood Test (2017)
  • Figure 14: North America Uterine Cancer Diagnostic Testing Market Value Share, By Country (2017)
  • Figure 15: North America Uterine Cancer Diagnostic Testing Market Value Share, By Cancer Type (2017)
  • Figure 16: North America Uterine Cancer Diagnostic Testing Market Value Share, By Diagnostic Test Type (2017)
  • Figure 17: North America Uterine Cancer Diagnostic Testing Market Value Share, By End-Users (2017)
  • Figure 18: North America Uterine Cancer Diagnostic Testing Market Size (US$ Mn) Analysis, 2013-2017
  • Figure 19: North America Uterine Cancer Diagnostic Testing Market Size (US$ Mn) & Y-o-Y Growth (%), 2018-2026
  • Figure 20: U.S. Uterine Cancer Diagnostic Testing Market Size (US$ Mn) Analysis, 2013-2017
  • Figure 21: U.S. Uterine Cancer Diagnostic Testing Market Value (US$ Mn) & Y-o-Y Growth (%), 2018-2026
  • Figure 22: Canada Uterine Cancer Diagnostic Testing Market Size (US$ Mn) Analysis, 2013-2017
  • Figure 23: Canada Uterine Cancer Diagnostic Testing Market Value (US$ Mn) & Y-o-Y Growth (%), 2018-2026
  • Figure 24: North America Uterine Cancer Diagnostic Testing Market Size (US$ Mn) Analysis, Endometrial Carcinoma, 2013-2017
  • Figure 25: North America Uterine Cancer Diagnostic Testing Market Value (US$ Mn) & Y-o-Y Growth (%), Endometrial Carcinoma, 2018-2026
  • Figure 26: North America Uterine Cancer Diagnostic Testing Market Size (US$ Mn) Analysis, Uterine Sarcoma, 2013-2017
  • Figure 27: North America Uterine Cancer Diagnostic Testing Market Value (US$ Mn) & Y-o-Y Growth (%), Uterine Sarcoma, 2018-2026
  • Figure 28: North America Uterine Cancer Diagnostic Testing Market Size (US$ Mn) Analysis, by Ultrasound Scanning, 2013-2017
  • Figure 29: North America Uterine Cancer Diagnostic Testing Market Value (US$ Mn) & Y-o-Y Growth (%), by Ultrasound Scanning 2018-2026
  • Figure 30: North America Uterine Cancer Diagnostic Testing Market Size (US$ Mn) Analysis, by Biopsy Procedure, 2013-2017
  • Figure 31: North America Uterine Cancer Diagnostic Testing Market Value (US$ Mn) & Y-o-Y Growth (%), by Biopsy Procedure, 2018-2026
  • Figure 32: North America Uterine Cancer Diagnostic Testing Market Size (US$ Mn) Analysis, by Blood Test, 2013-2017
  • Figure 33: North America Uterine Cancer Diagnostic Testing Market Value (US$ Mn) & Y-o-Y Growth (%), by Blood Test 2018-2026
  • Figure 34: North America Uterine Cancer Diagnostic Testing Market Size (US$ Mn) Analysis, Hospitals, and 2013-2017
  • Figure 35: North America Uterine Cancer Diagnostic Testing Market Value (US$ Mn) & Y-o-Y Growth (%), Hospitals, 2018-2026
  • Figure 36: North America Uterine Cancer Diagnostic Testing Market Size (US$ Mn) Analysis, Ambulatory Surgical Centers, and 2013-2017
  • Figure 37: North America Uterine Cancer Diagnostic Testing Market Value (US$ Mn) & Y-o-Y Growth (%), Ambulatory Surgical Centers, 2018-2026
  • Figure 38: North America Uterine Cancer Diagnostic Testing Market Size (US$ Mn) Analysis, Cancer Research Institutes, 2013-2017
  • Figure 39: North America Uterine Cancer Diagnostic Testing Market Value (US$ Mn) & Y-o-Y Growth (%), Cancer Research Institutes, 2018-2026
  • Figure 40: North America Uterine Cancer Diagnostic Testing Market Size (US$ Mn) Analysis, Specialized Clinics, and 2013-2017
  • Figure 41: North America Uterine Cancer Diagnostic Testing Market Value (US$ Mn) & Y-o-Y Growth (%), Specialized Clinics, 2018-2026
  • Figure 42: North America Uterine Cancer Diagnostic Testing Market Size (US$ Mn) Analysis, Diagnostic Laboratories, and 2013-2017
  • Figure 43: North America Uterine Cancer Diagnostic Testing Market Value (US$ Mn) & Y-o-Y Growth (%), Diagnostic Laboratories, 2018-2026
  • Figure 44: North America Uterine Cancer Diagnostic Testing Market Size (US$ Mn) Analysis, Others, 2013-2017
  • Figure 45: North America Uterine Cancer Diagnostic Testing Market Value (US$ Mn) & Y-o-Y Growth (%), Others, 2018-2026
  • Figure 46: North America Uterine Cancer Diagnostic Testing Market Attractiveness Analysis, By Country
  • Figure 47: North America Uterine Cancer Diagnostic Testing Market Attractiveness Analysis, By Cancer Type
  • Figure 48: North America Uterine Cancer Diagnostic Testing Market Attractiveness Analysis, By Diagnostic Test Type
  • Figure 49: North America Uterine Cancer Diagnostic Testing Market Attractiveness Analysis, By End-User
  • Figure 50: Latin America Uterine Cancer Diagnostic Testing Market Value Share, By Country (2017)
  • Figure 51: Latin America Uterine Cancer Diagnostic Testing Market Value Share, By Cancer Type (2017)
  • Figure 52: Latin America Uterine Cancer Diagnostic Testing Market Value Share, By Diagnostic Test Type (2017)
  • Figure 53: Latin America Uterine Cancer Diagnostic Testing Market Value Share, By End-Users (2017)
  • Figure 54: Latin America Uterine Cancer Diagnostic Testing Market Size (US$ Mn) Analysis, 2013-2017
  • Figure 55: Latin America Uterine Cancer Diagnostic Testing Market Size (US$ Mn) & Y-o-Y Growth (%), 2018-2026
  • Figure 56: Brazil Uterine Cancer Diagnostic Testing Market Size (US$ Mn) Analysis, 2013-2017
  • Figure 57: Brazil Uterine Cancer Diagnostic Testing Market Value (US$ Mn) & Y-o-Y Growth (%), 2018-2026
  • Figure 58: Mexico Uterine Cancer Diagnostic Testing Market Size (US$ Mn) Analysis, 2013-2017
  • Figure 59: Mexico Uterine Cancer Diagnostic Testing Market Value (US$ Mn) & Y-o-Y Growth (%), 2018-2026
  • Figure 60: Rest of Latin America Uterine Cancer Diagnostic Testing Market Size (US$ Mn) Analysis, 2013-2017
  • Figure 61: Rest of Latin America Uterine Cancer Diagnostic Testing Market Value (US$ Mn) & Y-o-Y Growth (%), 2018-2026
  • Figure 62: Latin America Uterine Cancer Diagnostic Testing Market Size (US$ Mn) Analysis, Endometrial Carcinoma, 2013-2017
  • Figure 63: Latin America Uterine Cancer Diagnostic Testing Market Value (US$ Mn) & Y-o-Y Growth (%), Endometrial Carcinoma, 2018-2026
  • Figure 64: Latin America Uterine Cancer Diagnostic Testing Market Size (US$ Mn) Analysis, Uterine Sarcoma, 2013-2017
  • Figure 65: Latin America Uterine Cancer Diagnostic Testing Market Value (US$ Mn) & Y-o-Y Growth (%), Uterine Sarcoma, 2018-2026
  • Figure 66: Latin America Uterine Cancer Diagnostic Testing Market Size (US$ Mn) Analysis, by Ultrasound Scanning, 2013-2017
  • Figure 67: Latin America Uterine Cancer Diagnostic Testing Market Value (US$ Mn) & Y-o-Y Growth (%), by Ultrasound Scanning, 2018-2026
  • Figure 68: Latin America Uterine Cancer Diagnostic Testing Market Size (US$ Mn) Analysis, by Biopsy Procedure, 2013-2017
  • Figure 69: Latin America Uterine Cancer Diagnostic Testing Market Value (US$ Mn) & Y-o-Y Growth (%), by Biopsy Procedure, 2018-2026
  • Figure 70: Latin America Uterine Cancer Diagnostic Testing Market Size (US$ Mn) Analysis, by Blood Test, 2013-2017
  • Figure 71: Latin America Uterine Cancer Diagnostic Testing Market Value (US$ Mn) & Y-o-Y Growth (%), by Blood Test 2018-2026
  • Figure 72: Latin America Uterine Cancer Diagnostic Testing Market Size (US$ Mn) Analysis, Hospitals, and 2013-2017
  • Figure 73: Latin America Uterine Cancer Diagnostic Testing Market Value (US$ Mn) & Y-o-Y Growth (%), Hospitals, 2018-2026
  • Figure 74: Latin America Uterine Cancer Diagnostic Testing Market Size (US$ Mn) Analysis, Ambulatory Surgical Centers, and 2013-2017
  • Figure 75: Latin America Uterine Cancer Diagnostic Testing Market Value (US$ Mn) & Y-o-Y Growth (%), Ambulatory Surgical Centers, 2018-2026
  • Figure 76: Latin America Uterine Cancer Diagnostic Testing Market Size (US$ Mn) Analysis, Cancer Research Institutes, 2013-2017
  • Figure 77: Latin America Uterine Cancer Diagnostic Testing Market Value (US$ Mn) & Y-o-Y Growth (%), Cancer Research Institutes, 2017-2026
  • Figure 78: Latin America Uterine Cancer Diagnostic Testing Market Size (US$ Mn) Analysis, Specialized Clinics, and 2013-2017
  • Figure 79: Latin America Uterine Cancer Diagnostic Testing Market Value (US$ Mn) & Y-o-Y Growth (%), Specialized Clinics, 2017-2026
  • Figure 80: Latin America Uterine Cancer Diagnostic Testing Market Size (US$ Mn) Analysis, Diagnostic Laboratories, and 2013-2017
  • Figure 81: Latin America Uterine Cancer Diagnostic Testing Market Value (US$ Mn) & Y-o-Y Growth (%), Diagnostic Laboratories, 2017-2026
  • Figure 82: Latin America Uterine Cancer Diagnostic Testing Market Size (US$ Mn) Analysis, Others, 2013-2017
  • Figure 83: Latin America Uterine Cancer Diagnostic Testing Market Value (US$ Mn) & Y-o-Y Growth (%), Others, 2017-2026
  • Figure 84: Latin America Uterine Cancer Diagnostic Testing Market Attractiveness Analysis, By Country
  • Figure 85: Latin America Uterine Cancer Diagnostic Testing Market Attractiveness Analysis, By Cancer Type
  • Figure 86: Latin America Uterine Cancer Diagnostic Testing Market Attractiveness Analysis, By Diagnostic Test Type
  • Figure 87: Latin America Uterine Cancer Diagnostic Testing Market Attractiveness Analysis, By End-User
  • Figure 88: Europe Uterine Cancer Diagnostic Testing Market Value Share, By Country (2017)
  • Figure 89: Europe Uterine Cancer Diagnostic Testing Market Value Share, By Cancer Type (2017)
  • Figure 90: Europe Uterine Cancer Diagnostic Testing Market Value Share, By Diagnostic Test Type (2017)
  • Figure 91: Europe Uterine Cancer Diagnostic Testing Market Value Share, By End-Users (2017)
  • Figure 92: Europe Uterine Cancer Diagnostic Testing Market Size (US$ Mn) Analysis, 2013-2017
  • Figure 93: Europe Uterine Cancer Diagnostic Testing Market Size (US$ Mn) & Y-o-Y Growth (%), 2018-2026
  • Figure 94: Russia Uterine Cancer Diagnostic Testing Market Size (US$ Mn) Analysis, 2013-2017
  • Figure 95: Russia Uterine Cancer Diagnostic Testing Market Value (US$ Mn) & Y-o-Y Growth (%), 2018-2026
  • Figure 96: Germany Uterine Cancer Diagnostic Testing Market Size (US$ Mn) Analysis, 2013-2017
  • Figure 97: Germany Uterine Cancer Diagnostic Testing Market Value (US$ Mn) & Y-o-Y Growth (%), 2018-2026
  • Figure 98: U.K Uterine Cancer Diagnostic Testing Market Size (US$ Mn) Analysis, 2013-2017
  • Figure 99: U.K Uterine Cancer Diagnostic Testing Market Value (US$ Mn) & Y-o-Y Growth (%), 2018-2026
  • Figure 100: France Uterine Cancer Diagnostic Testing Market Size (US$ Mn) Analysis, 2013-2017
  • Figure 101: France Uterine Cancer Diagnostic Testing Market Value (US$ Mn) & Y-o-Y Growth (%), 2018-2026
  • Figure 102: Italy Uterine Cancer Diagnostic Testing Market Size (US$ Mn) Analysis, 2013-2017
  • Figure 103: Italy Uterine Cancer Diagnostic Testing Market Value (US$ Mn) & Y-o-Y Growth (%), 2018-2026
  • Figure 104: Poland Uterine Cancer Diagnostic Testing Market Size (US$ Mn) Analysis, 2013-2017
  • Figure 105: Poland Uterine Cancer Diagnostic Testing Market Value (US$ Mn) & Y-o-Y Growth (%), 2018-2026
  • Figure 106: Spain Uterine Cancer Diagnostic Testing Market Size (US$ Mn) Analysis, 2013-2017
  • Figure 107: Spain Uterine Cancer Diagnostic Testing Market Value (US$ Mn) & Y-o-Y Growth (%), 2018-2026
  • Figure 108: Rest of Europe Uterine Cancer Diagnostic Testing Market Size (US$ Mn) Analysis, 2013-2017
  • Figure 109: Rest of Europe Uterine Cancer Diagnostic Testing Market Value (US$ Mn) & Y-o-Y Growth (%), 2018-2026
  • Figure 110: Europe Uterine Cancer Diagnostic Testing Market Size (US$ Mn) Analysis, Endometrial Carcinoma, 2013-2017
  • Figure 111: Europe Uterine Cancer Diagnostic Testing Market Value (US$ Mn) & Y-o-Y Growth (%), Endometrial Carcinoma, 2018-2026
  • Figure 112: Europe Uterine Cancer Diagnostic Testing Market Size (US$ Mn) Analysis, Uterine Sarcoma, 2013-2017
  • Figure 113: Europe Uterine Cancer Diagnostic Testing Market Value (US$ Mn) & Y-o-Y Growth (%), Uterine Sarcoma, 2018-2026
  • Figure 114: Europe Uterine Cancer Diagnostic Testing Market Size (US$ Mn) Analysis, by Ultrasound Scanning, 2013-2017
  • Figure 115: Europe Uterine Cancer Diagnostic Testing Market Value (US$ Mn) & Y-o-Y Growth (%), by Ultrasound Scanning2018-2026
  • Figure 116: Europe Uterine Cancer Diagnostic Testing Market Size (US$ Mn) Analysis, by Biopsy Procedure, 2013-2017
  • Figure 117: Europe Uterine Cancer Diagnostic Testing Market Value (US$ Mn) & Y-o-Y Growth (%), by Biopsy Procedure, 2018-2026
  • Figure 118: Europe Uterine Cancer Diagnostic Testing Market Size (US$ Mn) Analysis, by Blood Test, 2013-2017
  • Figure 119: Europe Uterine Cancer Diagnostic Testing Market Value (US$ Mn) & Y-o-Y Growth (%), by Blood Test 2017-2026
  • Figure 120: Europe Uterine Cancer Diagnostic Testing Market Size (US$ Mn) Analysis, Hospitals, and 2013-2017
  • Figure 121: Europe Uterine Cancer Diagnostic Testing Market Value (US$ Mn) & Y-o-Y Growth (%), Hospitals, 2018-2026
  • Figure 122: Europe Uterine Cancer Diagnostic Testing Market Size (US$ Mn) Analysis, Ambulatory Surgical Centers, and 2013-2017
  • Figure 123: Europe Uterine Cancer Diagnostic Testing Market Value (US$ Mn) & Y-o-Y Growth (%), Ambulatory Surgical Centers, 2018-2026
  • Figure 124: Europe Uterine Cancer Diagnostic Testing Market Size (US$ Mn) Analysis, Cancer Research Institutes, 2013-2017
  • Figure 125: Europe Uterine Cancer Diagnostic Testing Market Value (US$ Mn) & Y-o-Y Growth (%), Cancer Research Institutes, 2018-2026
  • Figure 126: Europe Uterine Cancer Diagnostic Testing Market Size (US$ Mn) Analysis, Specialized Clinics, and 2013-2017
  • Figure 127: Europe Uterine Cancer Diagnostic Testing Market Value (US$ Mn) & Y-o-Y Growth (%), Specialized Clinics, 2018-2026
  • Figure 128: Europe Uterine Cancer Diagnostic Testing Market Size (US$ Mn) Analysis, Diagnostic Laboratories, and 2013-2017
  • Figure 129: Europe Uterine Cancer Diagnostic Testing Market Value (US$ Mn) & Y-o-Y Growth (%), Diagnostic Laboratories, 2018-2026
  • Figure 130: Europe Uterine Cancer Diagnostic Testing Market Size (US$ Mn) Analysis, Others, 2013-2017
  • Figure 131: Europe Uterine Cancer Diagnostic Testing Market Value (US$ Mn) & Y-o-Y Growth (%), Others, 2018-2026
  • Figure 132: Europe Uterine Cancer Diagnostic Testing Market Attractiveness Analysis, By Country
  • Figure 133: Europe Uterine Cancer Diagnostic Testing Market Attractiveness Analysis, By Cancer Type
  • Figure 134: Europe Uterine Cancer Diagnostic Testing Market Attractiveness Analysis, By Diagnostic Test Type
  • Figure 135: Europe Uterine Cancer Diagnostic Testing Market Attractiveness Analysis, By End-User
  • Figure 136: Asia-Pacific Excluding China Uterine Cancer Diagnostic Testing Market Value Share, By Country (2017)
  • Figure 137: Asia-Pacific Excluding China Uterine Cancer Diagnostic Testing Market Value Share, By Cancer Type (2017)
  • Figure 138: Asia-Pacific Excluding China Uterine Cancer Diagnostic Testing Market Value Share, By Diagnostic Test Type (2017)
  • Figure 139: Asia-Pacific Excluding China Uterine Cancer Diagnostic Testing Market Value Share, By End-Users (2017)
  • Figure 140: Asia-Pacific excluding China Uterine Cancer Diagnostic Testing Market Size (US$ Mn) Analysis, 2013-2017
  • Figure 141: Asia-Pacific excluding China Uterine Cancer Diagnostic Testing Market Size (US$ Mn) & Y-o-Y Growth (%), 2018-2026
  • Figure 142: India Uterine Cancer Diagnostic Testing Market Size (US$ Mn) Analysis, 2013-2017
  • Figure 143: India Uterine Cancer Diagnostic Testing Market Value (US$ Mn) & Y-o-Y Growth (%), 2018-2026
  • Figure 144: Japan Uterine Cancer Diagnostic Testing Market Size (US$ Mn) Analysis, 2013-2017
  • Figure 145: Japan Uterine Cancer Diagnostic Testing Market Value (US$ Mn) & Y-o-Y Growth (%), 2018-2026
  • Figure 146: ASEAN Uterine Cancer Diagnostic Testing Market Size (US$ Mn) Analysis, 2013-2017
  • Figure 147: ASEAN Uterine Cancer Diagnostic Testing Market Value (US$ Mn) & Y-o-Y Growth (%), 2018-2026
  • Figure 148: Australia and New Zealand Uterine Cancer Diagnostic Testing Market Size (US$ Mn) Analysis, 2013-2017
  • Figure 149: Australia and New Zealand Uterine Cancer Diagnostic Testing Market Value (US$ Mn) & Y-o-Y Growth (%), 2018-2026
  • Figure 150: Rest of Asia-Pacific Excluding China Uterine Cancer Diagnostic Testing Market Size (US$ Mn) Analysis, 2013-2017
  • Figure 151: Rest of Asia-Pacific Excluding China Uterine Cancer Diagnostic Testing Market Value (US$ Mn) & Y-o-Y Growth (%), 2018-2026
  • Figure 152: Asia-Pacific excluding China Uterine Cancer Diagnostic Testing Market Size (US$ Mn) Analysis, Endometrial Carcinoma, 2013-2017
  • Figure 153: Asia-Pacific excluding China Uterine Cancer Diagnostic Testing Market Value (US$ Mn) & Y-o-Y Growth (%), Endometrial Carcinoma, 2018-2026
  • Figure 154: Asia-Pacific excluding China Uterine Cancer Diagnostic Testing Market Size (US$ Mn) Analysis, Uterine Sarcoma, 2013-2017
  • Figure 155: Asia-Pacific excluding China Uterine Cancer Diagnostic Testing Market Value (US$ Mn) & Y-o-Y Growth (%), Uterine Sarcoma, 2018-2026
  • Figure 156: Asia-Pacific excluding China Uterine Cancer Diagnostic Testing Market Size (US$ Mn) Analysis, by Ultrasound Scanning, 2013-2017
  • Figure 157: Asia-Pacific excluding China Uterine Cancer Diagnostic Testing Market Value (US$ Mn) & Y-o-Y Growth (%), by Ultrasound Scanning, 2018-2026
  • Figure 158: Asia-Pacific excluding China Uterine Cancer Diagnostic Testing Market Size (US$ Mn) Analysis, by Biopsy Procedure, 2013-2017
  • Figure 159: Asia-Pacific excluding China Uterine Cancer Diagnostic Testing Market Value (US$ Mn) & Y-o-Y Growth (%), by Biopsy Procedure, 2018-2026
  • Figure 160: Asia-Pacific excluding China Uterine Cancer Diagnostic Testing Market Size (US$ Mn) Analysis, by Blood Test, 2013-2017
  • Figure 161: Asia-Pacific excluding China Uterine Cancer Diagnostic Testing Market Value (US$ Mn) & Y-o-Y Growth (%), by Blood Test 2018-2026
  • Figure 162: Asia-Pacific excluding China Uterine Cancer Diagnostic Testing Market Size (US$ Mn) Analysis, Hospitals, and 2013-2017
  • Figure 163: Asia-Pacific excluding China Uterine Cancer Diagnostic Testing Market Value (US$ Mn) & Y-o-Y Growth (%), Hospitals, 2018-2026
  • Figure 164: Asia-Pacific excluding China Uterine Cancer Diagnostic Testing Market Size (US$ Mn) Analysis, Ambulatory Surgical Centers, 2013-2017
  • Figure 165: Asia-Pacific excluding China Uterine Cancer Diagnostic Testing Market Value (US$ Mn) & Y-o-Y Growth (%), Ambulatory Surgical Centers, 2018-2026
  • Figure 166: Asia-Pacific excluding China Uterine Cancer Diagnostic Testing Market Size (US$ Mn) Analysis, Cancer Research Institutes, and 2013-2017
  • Figure 167: Asia-Pacific excluding China Uterine Cancer Diagnostic Testing Market Value (US$ Mn) & Y-o-Y Growth (%), Cancer Research Institutes, 2018-2026
  • Figure 168: Asia-Pacific excluding China Uterine Cancer Diagnostic Testing Market Size (US$ Mn) Analysis, Specialized Clinics, and 2013-2017
  • Figure 169: Asia-Pacific excluding China Uterine Cancer Diagnostic Testing Market Value (US$ Mn) & Y-o-Y Growth (%), Specialized Clinics, 2018-2026
  • Figure 170: Asia-Pacific excluding China Uterine Cancer Diagnostic Testing Market Size (US$ Mn) Analysis, Diagnostic Laboratories, and 2013-2017
  • Figure 171: Asia-Pacific excluding China Uterine Cancer Diagnostic Testing Market Value (US$ Mn) & Y-o-Y Growth (%), Diagnostic Laboratories, 2018-2026
  • Figure 172: Asia-Pacific excluding China Uterine Cancer Diagnostic Testing Market Size (US$ Mn) Analysis, Others, 2013-2017
  • Figure 173: Asia-Pacific excluding China Uterine Cancer Diagnostic Testing Market Value (US$ Mn) & Y-o-Y Growth (%), others, 2018-2026
  • Figure 174: Asia-Pacific excluding China Uterine Cancer Diagnostic Testing Market Attractiveness Analysis, By Country
  • Figure 175: Asia-Pacific excluding China Uterine Cancer Diagnostic Testing Market Attractiveness Analysis, By Cancer Type
  • Figure 176: Asia-Pacific excluding China Uterine Cancer Diagnostic Testing Market Attractiveness Analysis, By Diagnostic Test Type
  • Figure 177: Asia-Pacific excluding China Uterine Cancer Diagnostic Testing Market Attractiveness Analysis, By End-User
  • Figure 178: China Uterine Cancer Diagnostic Testing Market Value Share, By Cancer Type (2017)
  • Figure 179: China Uterine Cancer Diagnostic Testing Market Value Share, By Diagnostic Test Type (2017)
  • Figure 180: China Uterine Cancer Diagnostic Testing Market Value Share, By End-Users (2017)
  • Figure 181: China Uterine Cancer Diagnostic Testing Market Size (US$ Mn) Analysis, 2013-2017
  • Figure 182: China Uterine Cancer Diagnostic Testing Market Size (US$ Mn) & Y-o-Y Growth (%), 2018-2026
  • Figure 183: China Uterine Cancer Diagnostic Testing Market Size (US$ Mn) Analysis, Endometrial Carcinoma, 2013-2017
  • Figure 184: China Uterine Cancer Diagnostic Testing Market Value (US$ Mn) & Y-o-Y Growth (%), Endometrial Carcinoma, 2018-2026
  • Figure 185: China Uterine Cancer Diagnostic Testing Market Size (US$ Mn) Analysis, Uterine Sarcoma, 2013-2017
  • Figure 186: China Uterine Cancer Diagnostic Testing Market Value (US$ Mn) & Y-o-Y Growth (%), Uterine Sarcoma, 2018-2026
  • Figure 187: China Uterine Cancer Diagnostic Testing Market Size (US$ Mn) Analysis, by Ultrasound Scanning, 2013-2017
  • Figure 188: China Uterine Cancer Diagnostic Testing Market Value (US$ Mn) & Y-o-Y Growth (%), by Ultrasound Scanning, 2018-2026
  • Figure 189: China Uterine Cancer Diagnostic Testing Market Size (US$ Mn) Analysis, by Biopsy Procedure, 2013-2017
  • Figure 190: China Uterine Cancer Diagnostic Testing Market Value (US$ Mn) & Y-o-Y Growth (%), by Biopsy Procedure, 2018-2026
  • Figure 191: China Uterine Cancer Diagnostic Testing Market Size (US$ Mn) Analysis, by Blood Test, 2013-2017
  • Figure 192: China Uterine Cancer Diagnostic Testing Market Value (US$ Mn) & Y-o-Y Growth (%), by Blood Test 2018-2026
  • Figure 193: China Uterine Cancer Diagnostic Testing Market Size (US$ Mn) Analysis, Hospitals, and 2013-2017
  • Figure 194: China Uterine Cancer Diagnostic Testing Market Value (US$ Mn) & Y-o-Y Growth (%), Hospitals, 2018-2026
  • Figure 195: China Uterine Cancer Diagnostic Testing Market Size (US$ Mn) Analysis, Ambulatory Surgical Centers, and 2013-2017
  • Figure 196: China Uterine Cancer Diagnostic Testing Market Value (US$ Mn) & Y-o-Y Growth (%), Ambulatory Surgical Centers, 2018-2026
  • Figure 197: China Uterine Cancer Diagnostic Testing Market Size (US$ Mn) Analysis, Cancer Research Institutes, 2013-2017
  • Figure 198: China Uterine Cancer Diagnostic Testing Market Value (US$ Mn) & Y-o-Y Growth (%), Cancer Research Institutes, 2017-2026
  • Figure 199: China Uterine Cancer Diagnostic Testing Market Size (US$ Mn) Analysis, Specialized Clinics, and 2013-2017
  • Figure 200: China Uterine Cancer Diagnostic Testing Market Value (US$ Mn) & Y-o-Y Growth (%), Specialized Clinics, 2017-2026
  • Figure 201: China Uterine Cancer Diagnostic Testing Market Size (US$ Mn) Analysis, Diagnostic Laboratories, and 2013-2017
  • Figure 202: China Uterine Cancer Diagnostic Testing Market Value (US$ Mn) & Y-o-Y Growth (%), Diagnostic Laboratories, 2018-2026
  • Figure 203: China Uterine Cancer Diagnostic Testing Market Size (US$ Mn) Analysis, Others, 2013-2017
  • Figure 204: China Uterine Cancer Diagnostic Testing Market Value (US$ Mn) & Y-o-Y Growth (%), Others, 2018-2026
  • Figure 205: China Uterine Cancer Diagnostic Testing Market Attractiveness Analysis, By Cancer Type
  • Figure 206: China Uterine Cancer Diagnostic Testing Market Attractiveness Analysis, By Diagnostic Test Type
  • Figure 207: China Uterine Cancer Diagnostic Testing Market Attractiveness Analysis, By End-User
  • Figure 208: Middle East and Africa Uterine Cancer Diagnostic Testing Market Value Share, By Country (2017)
  • Figure 209: Middle East and Africa Uterine Cancer Diagnostic Testing Market Value Share, By Cancer Type (2017)
  • Figure 210: Middle East and Africa Uterine Cancer Diagnostic Testing Market Value Share, By Diagnostic Test Type (2017)
  • Figure 211: Middle East and Africa Uterine Cancer Diagnostic Testing Market Value Share, By End-Users (2017)
  • Figure 212: Middle East and Africa Uterine Cancer Diagnostic Testing Market Size (US$ Mn) Analysis, 2013-2017
  • Figure 213: Middle East and Africa Uterine Cancer Diagnostic Testing Market Size (US$ Mn) & Y-o-Y Growth (%), 2018-2026
  • Figure 214: South Africa Uterine Cancer Diagnostic Testing Market Size (US$ Mn) Analysis, 2013-2017
  • Figure 215: South Africa Uterine Cancer Diagnostic Testing Market Value (US$ Mn) & Y-o-Y Growth (%), 2018-2026
  • Figure 216: Saudi Arabia Uterine Cancer Diagnostic Testing Market Size (US$ Mn) Analysis, 2013-2017
  • Figure 217: Saudi Arabia Uterine Cancer Diagnostic Testing Market Value (US$ Mn) & Y-o-Y Growth (%), 2018-2026
  • Figure 218: Rest of Middle East and Africa Uterine Cancer Diagnostic Testing Market Size (US$ Mn) Analysis, 2013-2017
  • Figure 219: Rest of Middle East and Africa Cancer Diagnostic Testing Market Value (US$ Mn) & Y-o-Y Growth (%), 2018-2026
  • Figure 220: Middle East and Africa Uterine Cancer Diagnostic Testing Market Size (US$ Mn) Analysis, Endometrial Carcinoma, 2013-2017
  • Figure 221: Middle East and Africa Uterine Cancer Diagnostic Testing Market Value (US$ Mn) & Y-o-Y Growth (%), Endometrial Carcinoma, 2018-2026
  • Figure 222: Middle East and Africa Uterine Cancer Diagnostic Testing Market Size (US$ Mn) Analysis, Uterine Sarcoma, 2013-2017
  • Figure 223: Middle East and Africa Uterine Cancer Diagnostic Testing Market Value (US$ Mn) & Y-o-Y Growth (%), Uterine Sarcoma, 2018-2026
  • Figure 224: Middle East and Africa Uterine Cancer Diagnostic Testing Market Size (US$ Mn) Analysis, by Ultrasound Scanning, 2013-2017
  • Figure 225: Middle East and Africa Uterine Cancer Diagnostic Testing Market Value (US$ Mn) & Y-o-Y Growth (%), by Ultrasound Scanning, 2018-2026
  • Figure 226: Middle East and Africa Uterine Cancer Diagnostic Testing Market Size (US$ Mn) Analysis, by Biopsy Procedure, 2013-2017
  • Figure 227: Middle East and Africa Uterine Cancer Diagnostic Testing Market Value (US$ Mn) & Y-o-Y Growth (%), by Biopsy Procedure, 2018-2026
  • Figure 228: Middle East and Africa Uterine Cancer Diagnostic Testing Market Size (US$ Mn) Analysis, by Blood Test, 2013-2017
  • Figure 229: Middle East and Africa Uterine Cancer Diagnostic Testing Market Value (US$ Mn) & Y-o-Y Growth (%), by Blood Test 2018-2026
  • Figure 230: Middle East and Africa Uterine Cancer Diagnostic Testing Market Size (US$ Mn) Analysis, Hospitals, and 2013-2017
  • Figure 231: Middle East and Africa Uterine Cancer Diagnostic Testing Market Value (US$ Mn) & Y-o-Y Growth (%), Hospitals, 2018-2026
  • Figure 232: Middle East and Africa Uterine Cancer Diagnostic Testing Market Size (US$ Mn) Analysis, Ambulatory Surgical Centers, and 2013-2017
  • Figure 233: Middle East and Africa Uterine Cancer Diagnostic Testing Market Value (US$ Mn) & Y-o-Y Growth (%), Ambulatory Surgical Centers, 2018-2026
  • Figure 234: Middle East and Africa Uterine Cancer Diagnostic Testing Market Size (US$ Mn) Analysis, Cancer Research Institutes, 2013-2017
  • Figure 235: Middle East and Africa Uterine Cancer Diagnostic Testing Market Value (US$ Mn) & Y-o-Y Growth (%), Cancer Research Institutes, 2018-2026
  • Figure 236: Middle East and Africa Uterine Cancer Diagnostic Testing Market Size (US$ Mn) Analysis, Specialized Clinics, and 2013-2017
  • Figure 237: Middle East and Africa Uterine Cancer Diagnostic Testing Market Value (US$ Mn) & Y-o-Y Growth (%), Specialized Clinics, 2018-2026
  • Figure 238: Middle East and Africa Uterine Cancer Diagnostic Testing Market Size (US$ Mn) Analysis, Diagnostic Laboratories, and 2013-2017
  • Figure 239: Middle East and Africa Uterine Cancer Diagnostic Testing Market Value (US$ Mn) & Y-o-Y Growth (%), Diagnostic Laboratories, 2018-2026
  • Figure 240: Middle East and Africa Uterine Cancer Diagnostic Testing Market Size (US$ Mn) Analysis, Others, 2013-2017
  • Figure 241: Middle East and Africa Uterine Cancer Diagnostic Testing Market Value (US$ Mn) & Y-o-Y Growth (%), Others, 2018-2026
  • Figure 242: Middle East and Africa Uterine Cancer Diagnostic Testing Market Attractiveness Analysis, By Country
  • Figure 243: Middle East and Africa Uterine Cancer Diagnostic Testing Market Attractiveness Analysis, By Cancer Type
  • Figure 244: Middle East and Africa Uterine Cancer Diagnostic Testing Market Attractiveness Analysis, By Diagnostic Test Type
  • Figure 245: Middle East and Africa Uterine Cancer Diagnostic Testing Market Attractiveness Analysis, By End-User
  • Figure 246: Global Uterine Cancer Diagnostic Testing Market Attractiveness Analysis by Region, 2018-2026
  • Figure 247: Global Uterine Cancer Diagnostic Testing Market Share Analysis (%) By Region, 2018 & 2026
  • Figure 248: Global Uterine Cancer Diagnostic Testing Market Y-o-Y Growth (%) By Region, 2018-2026
  • Figure 249: Global Uterine Cancer Diagnostic Testing Market Share Analysis (%) By Cancer Type, 2018 & 2026
  • Figure 250: Global Uterine Cancer Diagnostic Testing Market Y-o-Y Growth (%) By Cancer Type, 2018-2026
  • Figure 251: Global Uterine Cancer Diagnostic Testing Market Attractiveness Analysis by Cancer Type, 2018-2026
  • Figure 252: Global Uterine Cancer Diagnostic Testing Market Share Analysis (%) By Ultrasound Scanning, 2017 & 2026
  • Figure 253: Global Uterine Cancer Diagnostic Testing Market Y-o-Y Growth (%) By Ultrasound Scanning, 2017-2026
  • Figure 254: Global Uterine Cancer Diagnostic Testing Market Share Analysis (%) By Biopsy Procedure, 2017 & 2026
  • Figure 255: Global Uterine Cancer Diagnostic Testing Market Share Analysis (%) By Biopsy Procedure, 2017 & 2026
  • Figure 256: Global Uterine Cancer Diagnostic Testing Market Share Analysis (%) By Blood Test, 2017 & 2026
  • Figure 257: Global Uterine Cancer Diagnostic Testing Market Y-o-Y Growth (%) By Blood Test, 2017-2026
  • Figure 258: Global Uterine Cancer Diagnostic Testing Market Attractiveness Analysis by Ultrasound Scanning, 2018-2026
  • Figure 259: Global Uterine Cancer Diagnostic Testing Market Attractiveness Analysis by Biopsy Procedure, 2018-2026
  • Figure 260: Global Uterine Cancer Diagnostic Testing Market Attractiveness Analysis by Blood Test, 2018-2026
  • Figure 261: Global Uterine Cancer Diagnostic Testing Market Attractiveness Analysis by End User, 2017-2026
  • Figure 262: Global Uterine Cancer Diagnostic Testing Market Share Analysis (%) By End User, 2017 & 2026
  • Figure 263: Global Uterine Cancer Diagnostic Testing Market Y-o-Y Growth (%) By End User, 2018-2026
  • Figure 264: Global Uterine Cancer Diagnostic Testing Market Value Analysis and Forecast, 2018-2026 (US$ Mn)
  • Figure 265: Global Uterine Cancer Diagnostic Testing Market Value (US$ Mn), 2013-2017
  • Figure 266: Global Uterine Cancer Diagnostic Testing Market Absolute $ Opportunity (US$ Mn), 2017-2026